VANGUARD GROUP INC - ONCONOVA THERAPEUTICS INC ownership

ONCONOVA THERAPEUTICS INC's ticker is ONTXXXXX and the CUSIP is 68232V306. A total of 16 filers reported holding ONCONOVA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$232,000
-19.2%
574,367
+67.1%
0.00%
Q1 2018$287,000
+21.6%
343,701
+118.4%
0.00%
Q4 2017$236,000
+52.3%
157,401
+72.7%
0.00%
Q3 2017$155,000
-18.4%
91,140
+3.6%
0.00%
Q2 2017$190,000
+12.4%
87,940
+58.4%
0.00%
Q1 2017$169,000
+64.1%
55,522
+22.9%
0.00%
Q4 2016$103,000
+71.7%
45,172
+99.6%
0.00%
Q3 2016$60,000
-71.6%
22,632
-38.0%
0.00%
Q2 2016$211,00036,4990.00%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
TYNDALL CAPITAL PARTNERS L P 520,832$1,453,00078.80%
Boxer Capital, LLC 316,386$838,0000.38%
SABBY MANAGEMENT, LLC 392,023$1,039,0000.04%
Alambic Investment Management, L.P. 13,500$36,0000.01%
Weiss Multi-Strategy Advisers LLC 24,087$64,0000.00%
EAGLE GLOBAL ADVISORS LLC 16,680$44,0000.00%
NEXT Financial Group, Inc 0$00.00%
BANK OF AMERICA CORP /DE/ 2$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 77$00.00%
CITIGROUP INC 1,187$3,0000.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders